EBV-IN-1
EBV-IN-1 (Compound 15) is an antiviral agent. EBV-IN-1 has a potent antiviral activity against EBV with a EC50 of 0.17 μM. EBV-IN-1 also shows inhibitory effects on HIV (EC50: 20.8 μM) . EBV-IN-1 can be used for EBV and HIV infections research[1].
Product Specifications
UNSPSC
12352100
Target
EBV; HIV
Related Pathways
Anti-infection
Field of Research
Infection
Smiles
OC[C@@H]1OC[C@H](N2C(N=CN=C3N)=C3C(Br)=C2)O1
Molecular Formula
C10H11BrN4O3
Molecular Weight
315.12
References & Citations
[1]Singh U S, et al. Synthesis and Antiviral Evaluation of Unexplored Dioxolane-Derived 7-Deazapurine Nucleoside Analogues against Epstein–Barr Virus (EBV) [J]. ACS Medicinal Chemistry Letters, 2025.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC940676-500 1x 500 µL
MUC18 / Mucin 18 / CD146 (OJ79c), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470276-500 1x 500 µL
TAG-72 / CA72.4 (B72.3), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC042711-500 1x 500 µL
Carboxypeptidase A1 / CPA1 (Pancreatic Cancer Marker) (CPA1/2711), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC042375-100 1x 100 µL
Cytokeratin 14 (KRT14) (Squamous Cell Marker) (KRT14/2375), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740419-100 1x 100 µL
Transglutaminase II (TGM2/419), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details